# OnCo record mmr-ihc-panel-pharmdx (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mmr-ihc-panel-pharmdx/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "mmr-ihc-panel-pharmdx" ;
  schema:name "MMR IHC Panel pharmDx (Dako Omnis)"@en ;
  schema:description "Agilent's four-protein mismatch repair stain, approved in 2025 to select nivolumab, with or without ipilimumab, in bowel cancer."@en ;
  schema:url <https://onco.cc/drugs/mmr-ihc-panel-pharmdx/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P250004>, <https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "Immunohistochemistry companion diagnostic panel (mismatch repair proteins, colorectal tumour tissue)" ;
  schema:alternateName "MMR IHC Panel pharmDx" ;
  onco:approval "US 2025: Companion diagnostic for nivolumab alone or with ipilimumab in dMMR colorectal cancer" ;
  onco:related <https://onco.cc/drugs/ventana-mmr-rxdx/>, <https://onco.cc/drugs/idylla-cdx-msi/>, <https://onco.cc/biomarkers/dmmr-ihc/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/>, <https://onco.cc/technologies/histopathology-ihc/> ;
  onco:targets <https://onco.cc/targets/mmr/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/> ;
  onco:companies <https://onco.cc/companies/agilent/> ;
  onco:terms <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/msi/>, <https://onco.cc/terms/companion-diagnostic-term/> .